PCOS Estimated to Cost $8 Billion in Immediate, Long-term Health Issues

September 21st 2021, 1:00pm


An updated report shows that the long-term cost of treating the health effects of polycystic ovary syndrome (PCOS)—$4.3 billion—is even higher than $3.7 billion it takes to diagnose and treat immediate issues that present for women who are of reproductive age.

How Does GHD Affect the Oral, Dental Development of Children?

September 19th 2021, 12:15am


A systematic review that aimed to find out more about how growth hormone deficiency (GHD) affects children's oral and dental development found that knowledge gaps still remain.

Israeli Study Assesses Real-World Outcomes of Growth Hormone Treatment

September 18th 2021, 7:42pm


Real-world outcomes can differ from those seen in tightly-controlled clinical trials, so researchers wanted to examine the patterns of growth hormone treatment in a large cohort of children in Israel.

Study Details Findings of Phase 3 Trial for Once-Weekly Growth Hormone

September 11th 2021, 10:30am


This pivotal phase 3 trial led to the recent approval of lonapegsomatropin for growth hormone deficiency.

Contrast Agent May Be Unnecessary in MRIs Checking Pediatric Growth

September 8th 2021, 5:05pm


A review of cases using MRI with and without contrast agent found perfect or near-perfect agreement in most cases when evaluating patients with short stature for growth hormone deficiency.

Once-a-Week Somatropin Injection Cleared for Pediatric Growth Deficiency

September 3rd 2021, 1:45pm


The product, lonapegsomatropin, is a sustained-release formulation and could replace daily injections.

Machine Learning Predicts Incidence of Gestational Diabetes

December 30th 2020, 3:15pm


Using advanced machine learning models, researchers in China were able to accurately predict incidence of gestational diabetes among pregnant women during their first trimester.

Irregular Menstrual Cycles Associated With Increased Risk of T2D

December 28th 2020, 3:00pm


In a cohort study of nurses, irregular and long menstrual cycles throughout life were associated with a greater risk of type 2 diabetes (T2D).

Metformin Linked to Lower COVID-19 Mortality Rates Among Women With T2D, Obesity

December 8th 2020, 10:15pm


Among women hospitalized with coronavirus disease 2019 (COVID-19), use of metformin—a type 2 diabetes (T2D) drug used to manage blood sugar levels—was associated with a 21.5% lower risk of death.

Areas to Watch in Specialty Drug Pipeline Include Cancer, Orphan Drugs

October 23rd 2020, 8:35pm


In her presentation, Aimee Tharaldson, PhD, senior clinical pharmacist of emerging therapeutics at Express Scripts, discussed the upcoming pipeline of specialty drug approvals and their potential impact on the market.